Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Vaccitech (VACC) Competitors

Vaccitech logo

VACC vs. PROC, OPTN, VIRI, WHWK, VHAQ, PYRGF, OSTX, AADI, NBRV, and ATNM

Should you be buying Vaccitech stock or one of its competitors? The main competitors of Vaccitech include Procaps Group (PROC), OptiNose (OPTN), Virios Therapeutics (VIRI), Whitehawk Therapeutics (WHWK), Viveon Health Acquisition (VHAQ), PyroGenesis Canada (PYRGF), OS Therapies (OSTX), Aadi Bioscience (AADI), Nabriva Therapeutics (NBRV), and Actinium Pharmaceuticals (ATNM).

Vaccitech vs. Its Competitors

Vaccitech (NASDAQ:VACC) and Procaps Group (NASDAQ:PROC) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk.

Vaccitech has a beta of -0.4, meaning that its share price is 140% less volatile than the S&P 500. Comparatively, Procaps Group has a beta of -0.05, meaning that its share price is 105% less volatile than the S&P 500.

In the previous week, Vaccitech's average media sentiment score of 0.00 equaled Procaps Group'saverage media sentiment score.

Company Overall Sentiment
Vaccitech Neutral
Procaps Group Neutral

Procaps Group has higher revenue and earnings than Vaccitech.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vaccitech$13.42M2.83$5.34M-$1.43-0.69
Procaps Group$409.92M0.26$42.54MN/AN/A

26.1% of Vaccitech shares are held by institutional investors. 6.0% of Vaccitech shares are held by insiders. Comparatively, 19.9% of Procaps Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Procaps Group has a net margin of 0.00% compared to Vaccitech's net margin of -409.18%. Procaps Group's return on equity of 0.00% beat Vaccitech's return on equity.

Company Net Margins Return on Equity Return on Assets
Vaccitech-409.18% -23.41% -20.85%
Procaps Group N/A N/A N/A

Summary

Procaps Group beats Vaccitech on 7 of the 9 factors compared between the two stocks.

Get Vaccitech News Delivered to You Automatically

Sign up to receive the latest news and ratings for VACC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VACC vs. The Competition

MetricVaccitechPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$37.97M$790.52M$5.54B$8.99B
Dividend YieldN/A4.84%5.25%4.04%
P/E Ratio-0.691.3027.5520.17
Price / Sales2.83225.41432.66125.29
Price / Cash19.3023.4436.8257.86
Price / Book0.156.138.105.60
Net Income$5.34M-$27.58M$3.17B$248.58M

Vaccitech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VACC
Vaccitech
N/A$0.99
+6.2%
N/A-34.0%$37.97M$13.42M-0.6933
PROC
Procaps Group
N/A$0.95
-40.3%
N/A-62.0%$107.18M$409.92M0.004,900Gap Down
High Trading Volume
OPTN
OptiNose
0.7301 of 5 stars
$9.60
flat
$9.00
-6.3%
N/A$97.22M$81.86M-2.29190
VIRI
Virios Therapeutics
N/A$4.95
+3.8%
$5.00
+1.0%
+1,782.4%$95.33MN/A-18.335Gap Up
WHWK
Whitehawk Therapeutics
N/A$1.88
+1.1%
N/AN/A$88.57M$25.98M11.7540
VHAQ
Viveon Health Acquisition
N/A$11.00
flat
N/A+10.0%$62.26MN/A0.002High Trading Volume
PYRGF
PyroGenesis Canada
0.1033 of 5 stars
$0.33
flat
N/A-43.0%$62.17M$9.14M-5.5590News Coverage
Gap Down
OSTX
OS Therapies
2.7842 of 5 stars
$1.91
-1.0%
$18.00
+842.4%
N/A$53.67MN/A-2.22N/A
AADI
Aadi Bioscience
0.645 of 5 stars
$1.86
-0.5%
$1.67
-10.4%
+44.5%$45.94M$25.07M-0.8240
NBRV
Nabriva Therapeutics
N/AN/AN/AN/A$45.46M$35.59M0.0070
ATNM
Actinium Pharmaceuticals
2.9553 of 5 stars
$1.43
+5.9%
$4.00
+179.7%
N/A$44.61M$81K-1.0330

Related Companies and Tools


This page (NASDAQ:VACC) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners